GlassScriptPhysician profile
Martin W Muth
NPI 1306830211
$935.23
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $430 · 2021: $173.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $155.86 | 2020-2021 | |
| Abbvie INC. | $117.36 | 2019-2020 | |
| Therapeuticsmd, INC. | $111.53 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.65 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $95.63 | 2020 | |
| Allergan, INC. | $74.44 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $57.11 | 2019-2020 | |
| Ethicon US, LLC | $47.58 | 2019-2020 | |
| Lilly USA, LLC | $41.10 | 2019 | |
| Pulmonx Corporation | $34.80 | 2020 | |
| Pfizer INC. | $23.51 | 2020 | |
| Daiichi Sankyo INC. | $22.39 | 2019 | |
| Amgen INC. | $19.01 | 2019 | |
| Glaxosmithkline, LLC. | $16.29 | 2021 | |
| Exeltis, USA INC. | $12.97 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Muth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.